Skip to main content

AusPAR: Ezetimibe/ Simvastatin

Australian Public Assessment Report
Device/Product Name
Vytorin
Active ingredients
Ezetimibe/ Simvastatin
AusPAR Date
Published
Submission Number
PM-2011-01219-3-1
Submission Type
Extension of indications
Decision
Proposed Extension of Indication withdrawn. Revisions to Product Information, including to Dosage and Administration and Clinical Trials sections, approved

Help us improve the Therapeutic Goods Administration site